Andrew Reardon

CLO & Secretary

Andrew Reardon (CLO & Secretary) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $1.5M of LGND (4,796 sh across 6 lots, as filed), executed Jul 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.7M

shares × price, as filed

Last traded

Sep 3

Filed Sep 8

Median ADV $104.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

LGND

Ligand Pharmaceuticals Incorporated LGND · 0 buys · 9 sells 9 filings

Recent filings

LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $1.3M
4,700 sh across 4 lots
Exec Sep 3
Filed Sep 8 · 6:34 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $1.3M
4,505 sh across 6 lots
Exec Aug 3
Filed Aug 4 · 6:42 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $1.5M
4,796 sh across 6 lots
Exec Jul 1
Filed Jul 6 · 5:11 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $999K
4,400 sh across 5 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $1.0M
4,532 sh across 5 lots
Exec May 1
Filed May 4 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $846K
4,203 sh across 4 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $666K
3,200 sh across 3 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $104K
1,000 sh × $104.00
Exec May 15 2025
Filed Jun 2 2025 · 5:30 PM ET † More filings →